GALLO, Vittorio
GALLO, Vittorio
SCIENZE MEDICHE
A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis.
1990-01-01 SARACCO G ;ROSINA F ;TORRANI CERENZIA MR ;LATTORE V ;CHIANDUSSI L ;GALLO V ;PETRINO R ;DE MICHELI AG ;DONEGANI E ;SOLINAS A
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
1989-01-01 GALLO V ;CERUTTI E ;RIBERI A ;RE M ;PETRINO R ;PECCHIO F
Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis.
1990-01-01 SARACCO G ;TOUSCOZ A ;DURAZZO M ;ROSINA F ;DONEGANI E ;CHIANDUSSI L ;GALLO V ;PETRINO R ;DE MICHELI AG ;SOLINAS A
Deferiprone: New insight
2005-01-01 PIGA A; ROGGERO S; VINCIGUERRA T; SACCHETTI L; GALLO V; LONGO F
Ipertensione portale
2004-01-01 V.Gallo; L. Chiandussi
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
1993-01-01 SARACCO G ;ROSINA F ;ABATE ML ;CHIANDUSSI L ;GALLO V ;CERUTTI E ;DI NAPOLI A ;SOLINAS A ;DEPLANO A ;TOCCO A
Noninvasive assessment of spontaneous baroreflex sensitivity in patients with liver cirrhosis.
1998-01-01 VEGLIO F ;MELCHIO R ;CALVA S ;RABBIA F ;GALLO V ;MOLINO P ;MENGOZZI G ;MULATERO P ;MARTINI G ;RIVA P ;CHIANDUSSI L
Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases.
1994-01-01 GANDOLFO S ;CARBONE M ;CARROZZO M ;GALLO V
Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
1997-01-01 SARACCO G ;BORGHESIO E ;MESINA P ;SOLINAS A ;SPEZIA C ;MACOR F ;GALLO V ;CHIANDUSSI L ;DONADA C ;DONADON V ;SPIRITO F ;MASARACCO G ;BORGHESIO E ;MESINA P ;SOLINAS A ;SPEZIA C ;MACOR F ;GALLO V ;CHIANDUSSI L ;DONADA C ;DONADON V ;SPIRITO F ;MANGIA A ;ANDRIULLI A ;VERME G ;RIZZETTO M
SEGNI E SINTOMI INUSUALI O RARI IN MEDICINA INTERNA
2005-01-01 GALLO V.
Spontaneous release of interleukin 1 beta from human blood monocytes in thyrotoxic osteodystrophy.
1996-01-01 BISBOCCI D ;GALLO V ;DAMIANO P ;SIDOLI L ;CANTONI R ;AIMO G ;PRIOLO G ;PAGNI R ;CHIANDUSSI L
The 50 most-cited articles on clear aligner treatment: A bibliometric and visualized analysis
2021-01-01 Bruni, Alessandro; Serra, Francesca Giulia; Gallo, Vittorio; Deregibus, Andrea; Castroflorio, Tommaso
Treatment of acute alcohol withdrawal syndrome with carbamazepine: a double-blind comparison with tiapride.
1982-01-01 AGRICOLA R ;MAZZARINO M ;URANI R ;GALLO V ;GROSSI E
Two cases of congenital hepatic fibrosis in children of consanguineous marriage.
1990-01-01 MARINONE C ;DE MICHELI AG ;GALLO V ;BISBOCCI D ;CHIANDUSSI L
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis. | 1990 | SARACCO G ;ROSINA F ;TORRANI CERENZIA MR ;LATTORE V ;CHIANDUSSI L ;GALLO V ;PETRINO R ;DE MICHELI AG ;DONEGANI E ;SOLINAS A | |
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders. | 1989 | GALLO V ;CERUTTI E ;RIBERI A ;RE M ;PETRINO R ;PECCHIO F | |
Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis. | 1990 | SARACCO G ;TOUSCOZ A ;DURAZZO M ;ROSINA F ;DONEGANI E ;CHIANDUSSI L ;GALLO V ;PETRINO R ;DE MICHELI AG ;SOLINAS A | |
Deferiprone: New insight | 2005 | PIGA A; ROGGERO S; VINCIGUERRA T; SACCHETTI L; GALLO V; LONGO F | |
Ipertensione portale | 2004 | V.Gallo; L. Chiandussi | |
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b. | 1993 | SARACCO G ;ROSINA F ;ABATE ML ;CHIANDUSSI L ;GALLO V ;CERUTTI E ;DI NAPOLI A ;SOLINAS A ;DEPLANO A ;TOCCO A | |
Noninvasive assessment of spontaneous baroreflex sensitivity in patients with liver cirrhosis. | 1998 | VEGLIO F ;MELCHIO R ;CALVA S ;RABBIA F ;GALLO V ;MOLINO P ;MENGOZZI G ;MULATERO P ;MARTINI G ;RIVA P ;CHIANDUSSI L | |
Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. | 1994 | GANDOLFO S ;CARBONE M ;CARROZZO M ;GALLO V | |
Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial. | 1997 | SARACCO G ;BORGHESIO E ;MESINA P ;SOLINAS A ;SPEZIA C ;MACOR F ;GALLO V ;CHIANDUSSI L ;DONADA C ;DONADON V ;SPIRITO F ;MASARACCO G ;BORGHESIO E ;MESINA P ;SOLINAS A ;SPEZIA C ;MACOR F ;GALLO V ;CHIANDUSSI L ;DONADA C ;DONADON V ;SPIRITO F ;MANGIA A ;ANDRIULLI A ;VERME G ;RIZZETTO M | |
SEGNI E SINTOMI INUSUALI O RARI IN MEDICINA INTERNA | 2005 | GALLO V. | |
Spontaneous release of interleukin 1 beta from human blood monocytes in thyrotoxic osteodystrophy. | 1996 | BISBOCCI D ;GALLO V ;DAMIANO P ;SIDOLI L ;CANTONI R ;AIMO G ;PRIOLO G ;PAGNI R ;CHIANDUSSI L | |
The 50 most-cited articles on clear aligner treatment: A bibliometric and visualized analysis | 2021 | Bruni, Alessandro; Serra, Francesca Giulia; Gallo, Vittorio; Deregibus, Andrea; Castroflorio, Tommaso | |
Treatment of acute alcohol withdrawal syndrome with carbamazepine: a double-blind comparison with tiapride. | 1982 | AGRICOLA R ;MAZZARINO M ;URANI R ;GALLO V ;GROSSI E | |
Two cases of congenital hepatic fibrosis in children of consanguineous marriage. | 1990 | MARINONE C ;DE MICHELI AG ;GALLO V ;BISBOCCI D ;CHIANDUSSI L |